Please wait
Filed pursuant to Rule 424(b)(3)
Registration No. 333-258982
PROSPECTUS
$175,000,000
Common Stock
Preferred Stock
Debt Securities
We may
issue securities from time to time in one or more offerings, in
amounts, at prices and on terms determined at the time of offering.
This prospectus describes the general terms of these securities and
the general manner in which these securities will be offered. We
will provide the specific terms of these securities in supplements
to this prospectus, which will also describe the specific manner in
which these securities will be offered and may also supplement,
update or amend information contained in this prospectus. You
should read this prospectus and any applicable prospectus
supplement before you invest. The
aggregate offering price of the securities we sell pursuant to this
prospectus will not exceed $175,000,000.
The
securities may be sold directly to you, through agents or through
underwriters and dealers. If agents, underwriters or dealers are
used to sell the securities, we will name them and describe their
compensation in a prospectus supplement. The price to the public of
those securities and the net proceeds we expect to receive from
that sale will also be set forth in a prospectus
supplement.
Our
common stock is listed on the
Nasdaq Global Market under the symbol “LOOP.” Each
prospectus supplement will indicate whether the securities offered
thereby will be listed on any securities exchange.
Investing
in our securities involves risks. Please carefully read the
information under the headings “Risk Factors” beginning
on page 3 of this prospectus and “Item 1A–Risk
Factors” of our most recent report on Form 10-K or 10-Q that
is incorporated by reference in this prospectus before you invest
in our securities.
Neither
the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or
passed upon the adequacy or accuracy of this prospectus. Any
representation to the contrary is a criminal offense.
The date of this
prospectus is September 2, 2021.
TABLE OF CONTENTS
Page
|
About this Prospectus
|
ii
|
|
Definitions
|
ii
|
|
Prospectus Summary
|
1
|
|
Risk Factors
|
3
|
|
Cautionary Statements Regarding Forward-Looking
Statements
|
4
|
|
Industry and Market Data
|
5
|
|
Use of Proceeds
|
6
|
|
Description of Capital Stock
|
7
|
|
Description of Debt Securities
|
7
|
|
Plan of Distribution
|
14
|
|
Legal Matters
|
19
|
|
Experts
|
19
|
|
Where You Can Find More Information
|
19
|
|
Incorporation by Reference
|
20
|
ABOUT THIS PROSPECTUS
This
prospectus is part of a registration statement that we filed with
the Securities and Exchange Commission, or the SEC, using a
“shelf” registration process. Under this shelf
registration process, we may from time to time sell any combination
of the securities described in this prospectus in one or more
offerings.
This
prospectus provides you with a general description of the
securities that may be offered. Each time we sell securities, we
will provide one or more prospectus supplements that will contain
specific information about the terms of the offering. The
prospectus supplement may also add, update or change information
contained in this prospectus. You should read both this prospectus
and any applicable prospectus supplement together with the
additional information described under the heading “Where You
Can Find More Information.”
We have
not authorized anyone to provide you with information that is
different from that contained, or incorporated by reference, in
this prospectus, any applicable prospectus supplement or in any
related free writing prospectus. We take no responsibility for, and
can provide no assurance as to the reliability of, any other
information that others may give you. This prospectus and any
applicable prospectus supplement or any related free writing
prospectus do not constitute an offer to sell or the solicitation
of an offer to buy any securities other than the securities
described in the applicable prospectus supplement or an offer to
sell or the solicitation of an offer to buy such securities in any
circumstances in which such offer or solicitation is unlawful. You
should assume that the information appearing in this prospectus,
any prospectus supplement, the documents incorporated by reference
and any related free writing prospectus is accurate only as of
their respective dates. Our business, financial condition, results
of operations and prospects may have changed materially since those
dates.
For
investors outside the United States: We have not done anything that
would permit our public offering or possession or distribution of
this prospectus in any jurisdiction where action for that purpose
is required, other than in the United States. Persons outside the
United States who come into possession of this prospectus must
inform themselves about, and observe any restrictions relating to,
the offering of the securities and the distribution of this
prospectus outside of the United States.
DEFINITIONS
As
used in this prospectus, the following terms are being provided so
investors can better understand our business:
Depolymerization refers
to the chemical process of breaking a polymer down into its monomer
component(s), or smaller oligomers.
PET is an acronym for polyethylene
terephthalate, which is a resin and a type of polyester showing
excellent tensile and impact strength, chemical resistance,
clarity, and processability, and reasonable thermal stability. PET
is the material which is most commonly used for the production of
polyester fiber, and plastic packaging, including plastic bottles
for water and carbonated soft drinks, and containers for food and
other consumer products; it is commonly identified by the number
“1,” often inside an image of a triangle, on the
packaging. PET is also used as a polyester fiber for a variety of
applications including textiles, clothing and
apparel.
|
|
PROSPECTUS SUMMARY
This summary highlights selected information that is presented in
greater detail elsewhere, or incorporated by reference, in this
prospectus. It does not contain all of the information that may be
important to you and your investment decision. Before investing in
our securities, you should carefully read this entire prospectus,
including the matters set forth under the section of this
prospectus captioned “Risk Factors” and the financial
statements and related notes and other information that we
incorporate by reference herein, including our Annual Report on
Form 10-K and our Quarterly Reports on Form 10-Q. Unless the
context indicates otherwise, references in this prospectus to
“Loop Industries, Inc.,” “Loop,” “the
Company,” “we,” “our” and
“us” refer, collectively, to Loop Industries, Inc., a
Nevada corporation, and its consolidated subsidiaries taken as a
whole.
Company Overview
We are
a technology company whose mission is to accelerate the
world’s shift toward sustainable PET plastic and polyester
fiber and away from our dependence on fossil fuels. We own patented
and proprietary technology that depolymerizes no and low-value
waste PET plastic and polyester fiber, including plastic bottles
and packaging, carpets and textiles of any color, transparency or
condition and even ocean plastics that have been degraded by the
sun and salt, to its base building blocks (monomers). The monomers
are filtered, purified and polymerized to create virgin-quality
Loop™ branded PET resin suitable for use in food-grade
packaging and polyester fiber, thus enabling our customers to meet
their sustainability objectives. Loop Industries is contributing to
the global movement towards a circular economy by reducing plastic
waste and recovering waste plastic for a sustainable
future.
Consumer brands are
seeking a solution to their plastic challenge, and they are taking
bold action. In the past years, we have seen major brands make
significant commitments to close the loop on their plastic use in
two ways; by transitioning their packaging to recyclable materials
and by incorporating more recycled content into their packaging. We
believe Loop™ PET resin and polyester fiber provides the
ideal solution for these brands because it is recyclable and
is made from 100% recycled waste PET and polyester fiber, while
being virgin-quality and suitable for use in food-grade
packaging.
Corporate Information
We were
originally incorporated in Nevada in March 2010 under the name
Radikal Phones Inc., which was changed to First American Group Inc.
in October 2010. On June 29, 2015, we completed a reverse
acquisition of Loop Holdings, Inc. (“Loop Holdings”)
whereby we acquired all of Loop Holdings’ issued and
outstanding shares of common stock in a share exchange for
approximately 78.1% of our capital stock at the time. The
depolymerization business of Loop Holdings became our sole
operating business. On June 22, 2015, our board of directors
approved a change in the fiscal year end date from September 30 to
the last day of February. On July 21, 2015, we changed our name to
Loop Industries, Inc.
Loop
Holdings was originally incorporated in Nevada on October 23, 2014.
On May 24, 2016, 9449507 Canada Inc. was organized under the
federal laws of Canada and on November 11, 2016 became a
wholly-owned subsidiary of Loop Industries, Inc. following the
transfer by Mr. Solomita of all of the issued and outstanding
shares of common stock of 9449507 Canada Inc. to Loop Industries,
Inc. On December 23, 2016, 9449507 Canada Inc. changed its legal
name to Loop Canada Inc. On December 31, 2016, 8198381 Canada Inc.
entered into a purchase and sale agreement to transfer to Loop
Canada Inc., all assets and liabilities it held pertaining to our
business of depolymerizing plastics, including employees and
operations. On March 9, 2017, Loop Holdings, our wholly-owned
subsidiary, merged with and into Loop Industries, Inc., with Loop
Industries, Inc. being the surviving entity as a result of the
merger.
On November
20, 2017, Loop Industries, Inc. commenced trading on the Nasdaq
Global Market under its new trading symbol, “LOOP.”
From April 10, 2017 to November 19, 2017, our common
stock was quoted on the OTCQX tier of the OTC Markets
Group Inc. under the symbol “LLPP.” From October 29,
2015 through April 7, 2017, our common stock was quoted on the
OTCQB tier of the OTC Markets Group Inc. under the stock symbol
“LLPP.” From September 26, 2012 to October 28, 2015,
our common stock was quoted on the OTCQB tier of the OTC Markets
Group Inc. under the stock symbol “FAMG.”
Our
principal executive offices are located at 480 Fernand-Poitras
Street Terrebonne, Québec J6Y 1Y4 Canada. Our telephone number
is (450) 951-8555. Our website address is
http://www.loopindustries.com. The information contained on, or
that can be accessed through, our website is not incorporated by
reference in this prospectus and should not be considered to be
part of this prospectus.
|
|
|
|
The Securities That May Be Offered
We may offer or sell common stock, preferred stock
and debt securities in one or more offerings and in any
combination. The aggregate offering price of the securities
we sell pursuant to this prospectus will not exceed $175,000,000. Each time securities are offered with
this prospectus, we will provide a prospectus supplement that will
describe the specific amounts, prices and terms of the securities
being offered and the net proceeds we expect to receive from that
sale.
The
securities may be sold to or through underwriters, dealers or
agents or through a combination of any of these methods of sale or
directly to purchasers or as otherwise set forth in the section of
this prospectus captioned “Plan of Distribution.” We
and, as well as any agents acting on our or their behalf, reserve
the sole right to accept and to reject in whole or in part any
proposed purchase of securities. Each prospectus supplement will
set forth the names of any underwriters, dealers, agents or other
entities involved in the sale of securities described in that
prospectus supplement and any applicable fee, commission or
discount arrangements with them.
Common Stock
We
may offer shares of our common stock,
par value $0.0001 per share, either alone or underlying other
registered securities convertible into our common stock. Holders of
our common stock are entitled to receive dividends declared by our
board of directors out of funds legally available for the payment
of dividends, subject to rights, if any, of preferred shareholders.
We have not paid dividends in the past and have no current plans to
pay dividends. Each holder of common stock is entitled to one vote
per share. The holders of common stock have no preemptive
rights.
Preferred Stock
Our board of directors has the authority, subject
to limitations prescribed by Nevada law, to issue preferred stock in one or more
series, to establish from time to time the number of shares to be
included in each series, and to fix or alter the rights,
designation, powers, preferences and privileges of the preferred
stock, along with any limitations or restrictions, including voting
rights, dividend rights, conversion rights, redemption privileges
and liquidation preferences of each class or series of preferred
stock. Each series of preferred stock offered by us will be more
fully described in the particular prospectus supplement that will
accompany this prospectus, including redemption provisions, rights
in the event of our liquidation, dissolution or winding up, voting
rights and rights to convert into common stock.
Debt Securities
We
may offer secured or unsecured obligations in the form of one or
more series of debt securities, which may be senior, senior
subordinated or subordinated obligations. The senior debt
securities and the subordinated debt securities are together
referred to in this prospectus as the “debt
securities.” The subordinated debt securities are together
referred to in this prospectus as the “debt
securities.” The subordinated debt securities generally will
be entitled to payment only after payment of our senior debt.
Senior debt generally includes all debt for money borrowed by us,
except debt that is stated in the instrument governing the terms of
that debt to be not senior to, or to have the same rank in right of
payment as, or to be expressly junior to, the subordinated debt
securities. We may issue debt securities that are convertible into
shares of our common stock.
The debt securities will be issued under an
indenture, as supplemented by a resolution of our board of
directors, an officer’s certificate or a supplemental
indenture, between us and a trustee to be identified in an
accompanying prospectus supplement. We have summarized the general
features of the debt securities to be governed by the indenture in
this prospectus and the form of indenture has been filed as an exhibit to the
registration statement of which this prospectus forms a part. We
encourage you to read the indenture.
|
|
RISK FACTORS
An
investment in our securities involves a high degree of risk. The
prospectus supplement applicable to each offering of our securities
will contain a discussion of the risks applicable to an investment
in our securities. Prior to making a decision about investing in
our securities, you should carefully consider the specific factors
discussed under the section in the applicable prospectus supplement
captioned “Risk Factors,” together with all of the
other information contained or incorporated by reference in the
prospectus supplement or appearing or incorporated by reference in
this prospectus. You should also consider the risks, uncertainties
and assumptions discussed under Part I—Item
1A—Risk Factors of our most recent Annual Report on
Form 10-K and in
“Part II—Item 1A—Risk Factors” in
our most recent Quarterly Report on Form 10-Q filed subsequent
to such Form 10-K that are incorporated herein by reference, as may
be amended, supplemented or superseded from time to time by other
reports we file with the SEC in the future. The risks and
uncertainties we have described are not the only ones we face.
Additional risks and uncertainties not presently known to us or
that we currently deem immaterial may also affect our
operations.
CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING
STATEMENTS
This
prospectus, each prospectus supplement and the information
incorporated by reference in this prospectus and each prospectus
supplement contain certain statements that constitute
“forward-looking statements” within the meaning of
Section 27A of the Securities Act of 1933, as amended, or the
Securities Act, and Section 21E of the Securities Exchange Act
of 1934, as amended, or the Exchange Act. In some cases, you can
identify forward-looking statements by terminology such as
“may,” “will,” “should,”
“could,” “expects,” “plans,”
“intends,” “anticipates,”
“believes,” “estimates,”
“predicts,” “potential” or
“continue” or the negative of such terms and other
comparable terminology. These forward-looking statements include,
without limitation, statements about our market opportunity, our
strategies, ability to improve and expand our capabilities,
competition, expected activities and expenditures as we pursue our
business plan, the adequacy of our available cash resources,
regulatory compliance, plans for future growth and future
operations, the size of our addressable market, market trends, and
the effectiveness of the Company’s internal control over
financial reporting. Although we believe that the expectations
reflected in the forward-looking statements are reasonable, we
cannot guarantee future results, levels of activity, performance or
achievements. Actual results may differ materially from the
predictions discussed in these forward-looking statements. The
economic environment within which we operate could materially
affect our actual results. Forward-looking statements are
inherently subject to risks and uncertainties, some of which cannot
be predicted or quantified. These risks and other factors include,
but are not limited to, those listed under “Risk
Factors.” Additional factors that could materially affect
these forward-looking statements and/or predictions include, among
other things: (i) commercialization of our technology and
products, (ii) our status of relationship with
partners, (iii) development and protection of our intellectual
property and products, (iv) industry competition, (v) our need for
and ability to obtain additional funding, (vi) engineering,
locating, permitting, environmental and government approvals and
building our planned manufacturing facilities, (vii) our ability to
scale, secure appropriate feedstock volumes and costs, manufacture,
and sell our products in order to generate revenues, (viii) our
proposed business model and our ability to execute
thereon, (ix) adverse effects on the Company’s business
and operations as a result of increased regulatory, media or
financial reporting scrutiny, practices, rumors, or otherwise, (x)
disease epidemics and health related concerns, such as the current
outbreak of a novel strain of coronavirus (COVID-19), which
could result in (and, in the case of the COVID-19 outbreak, has
resulted in some of the following) reduced access to capital
markets, supply chain disruptions and scrutiny or embargoing of
goods produced in affected areas, government-imposed mandatory
business closures and resulting furloughs of our employees,
government employment subsidy programs, travel restrictions or the
like to prevent the spread of disease, and market or other changes
that could result in noncash impairments of our intangible assets,
and property, plant and equipment, (xi) the outcome of the current
SEC investigation or recent class action litigation filed against
us, (xii) our ability to hire and/or retain qualified employees and
consultants and (xiii) other factors discussed in our subsequent
filings with the SEC.
Management
has included projections and estimates in this prospectus, which
are based primarily on management’s experience in the
industry, assessments of our results of operations, discussions and
negotiations with third parties and a review of information filed
by our competitors with the SEC or otherwise publicly
available.
You
are cautioned that any such forward-looking statements are not
guarantees of future performance and involve risks and
uncertainties, and that actual results may differ materially from
those projected in the forward-looking statements as a result of
various factors.
Because
forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted or quantified, you
should not rely upon forward-looking statements as predictions of
future events. The events and circumstances reflected in the
forward-looking statements may not be achieved or occur and actual
results could differ materially from those projected in the
forward-looking statements. Except as required by applicable law,
including the securities laws of the United States and the rules
and regulations of the SEC, we do not plan to publicly update or
revise any forward-looking statements contained herein after we
distribute this prospectus, whether as a result of any new
information, future events or otherwise.
In
addition, statements that “we believe” and similar
statements reflect our beliefs and opinions on the relevant
subject. These statements are based upon information available to
us as of the date of this prospectus, and although we believe such
information forms a reasonable basis for such statements, such
information may be limited or incomplete, and our statements should
not be read to indicate that we have conducted a thorough inquiry
into, or review of, all potentially available relevant information.
These statements are inherently uncertain and investors are
cautioned not to unduly rely upon these statements.
INDUSTRY AND MARKET DATA
This
prospectus and the documents incorporated by reference in this
prospectus may contain industry and market data that we obtain from
our internal estimates and research, as well as publications,
research, surveys and studies conducted by independent third
parties not affiliated to us and industry sources. These sources do
not guarantee the accuracy or completeness of the information.
We include data obtained from
International Bottled Water Association (found at
https://www.bottledwater.org/) and various North American
PET index data from IHS Markit (found at
https://ihsmarkit.com/index.html).
Industry publications, studies and surveys
generally state that they were prepared based on sources believed
to be reliable, although there is no guarantee of accuracy. While
we believe that each of these studies and publications is reliable,
we have not independently verified the market and industry data
provided by third-party sources. In addition, while we believe our
internal research is reliable, not all such research has been
verified by any independent source. The market data may
include projections that are based on a number of other projections
or third party North American or European PET indexes. While we
believe these assumptions to be reasonable and sound as of the date
of this prospectus, actual results may differ from the projections.
We note that assumptions underlying
industry and market data are subject to change over time,
risks and uncertainties, including
those discussed under “Item 1A—Risk Factors” of
this prospectus.
USE OF PROCEEDS
We will retain broad discretion over the use of
the net proceeds to us from the sale of our securities under this
prospectus. Unless otherwise provided in the applicable prospectus
supplement, we currently expect to use the net proceeds that
we receive from this offering for working capital and other general
corporate purposes. We may also use a portion of the net proceeds
to acquire, license or invest in complementary products,
technologies or businesses; however, we currently have no
agreements or commitments to complete any such transaction. The
expected use of net proceeds of this offering represents our
current intentions based on our present plans and business
conditions. We cannot specify with certainty all of the particular
uses for the net proceeds to be received upon the closing of this
offering.
DESCRIPTION OF CAPITAL STOCK
The
description of our capital stock is incorporated by reference to
Exhibit 4.1 to our Annual Report on Form 10-K for the
fiscal year ended February 28, 2021, filed with the SEC on June 1,
2021.
DESCRIPTION OF DEBT SECURITIES
The
following description, together with the additional information we
include in any applicable prospectus supplement, summarizes certain
general terms and provisions of the debt securities that we may
offer under this prospectus. When we offer to sell a particular
series of debt securities, we will describe the specific terms of
the series in a supplement to this prospectus. We will also
indicate in the supplement to what extent the general terms and
provisions described in this prospectus apply to a particular
series of debt securities.
We may
issue debt securities either separately, or together with, or upon
the conversion or exercise of or in exchange for, other securities
described in this prospectus. Debt securities may be our senior,
senior subordinated or subordinated obligations and, unless
otherwise specified in a supplement to this prospectus, the debt
securities will be our direct, unsecured obligations and may be
issued in one or more series.
The
debt securities will be issued under an indenture between us and a
trustee to be identified in an accompanying prospectus supplement.
We have summarized select portions of the indenture below. The
summary is not complete. The form of the indenture has been filed
as an exhibit to the registration statement of which this
prospectus forms a part and you should read the indenture for
provisions that may be important to you. In the summary below, we
have included references to the section numbers of the indenture so
that you can easily locate these provisions. Capitalized terms used
in the summary and not defined herein have the meanings specified
in the indenture.
General
The
terms of each series of debt securities will be established by or
pursuant to a resolution of our board of directors and set forth or
determined in the manner provided in a resolution of our board of
directors, in an officer’s certificate or by a supplemental
indenture. The particular terms of each series of debt securities
will be described in a prospectus supplement relating to such
series (including any pricing supplement or term
sheet).
We can
issue an unlimited amount of debt securities under the indenture
that may be in one or more series with the same or various
maturities, at par, at a premium, or at a discount. We will set
forth in a prospectus supplement (including any pricing supplement
or term sheet) relating to any series of debt securities being
offered the aggregate principal amount and the following terms of
the debt securities, if applicable:
●
the title and
ranking of the debt securities (including the terms of any
subordination provisions);
●
the price or prices
(expressed as a percentage of the principal amount) at which we
will sell the debt securities;
●
any limit upon the
aggregate principal amount of the debt securities;
●
the date or dates
on which the principal of the securities of the series is
payable;
●
the rate or rates
(which may be fixed or variable) per annum or the method used to
determine the rate or rates (including any commodity, commodity
index, stock exchange index or financial index) at which the debt
securities will bear interest, the date or dates from which
interest will accrue, the date or dates on which interest will
commence and be payable and any regular record date for the
interest payable on any interest payment date;
●
the place or places
where principal of, and interest, if any, on the debt securities
will be payable (and the method of such payment), where the
securities of such series may be surrendered for registration of
transfer or exchange, and where notices and demands to us in
respect of the debt securities may be delivered;
●
the period or
periods within which, the price or prices at which and the terms
and conditions upon which we may redeem the debt
securities;
●
any obligation we
have to redeem or purchase the debt securities pursuant to any
sinking fund or analogous provisions or at the option of a holder
of debt securities and the period or periods within which, the
price or prices at which and the terms and conditions upon which
securities of the series shall be redeemed or purchased, in whole
or in part, pursuant to such obligation;
●
the dates on which
and the price or prices at which we will repurchase debt securities
at the option of the holders of debt securities and other detailed
terms and provisions of these repurchase obligations;
●
the denominations
in which the debt securities will be issued, if other than
denominations of $1,000 and any integral multiple
thereof;
●
whether the debt
securities will be issued in the form of certificated debt
securities or global debt securities;
●
the portion of
principal amount of the debt securities payable upon declaration of
acceleration of the maturity date, if other than the principal
amount;
●
the currency of
denomination of the debt securities, which may be United States
dollars or any foreign currency, and if such currency of
denomination is a composite currency, the agency or organization,
if any, responsible for overseeing such composite
currency;
●
the designation of
the currency, currencies or currency units in which payment of
principal of, premium and interest on the debt securities will be
made;
●
if payments of
principal of, premium or interest on the debt securities will be
made in one or more currencies or currency units other than that or
those in which the debt securities are denominated, the manner in
which the exchange rate with respect to these payments will be
determined;
●
the manner in which
the amounts of payment of principal of, premium, if any, or
interest on the debt securities will be determined, if these
amounts may be determined by reference to an index based on a
currency or currencies or by reference to a commodity, commodity
index, stock exchange index or financial index;
●
any provisions
relating to any security provided for the debt
securities;
●
any addition to,
deletion of or change in the Events of Default described in this
prospectus or in the indenture with respect to the debt securities
and any change in the acceleration provisions described in this
prospectus or in the indenture with respect to the debt
securities;
●
any addition to,
deletion of or change in the covenants described in this prospectus
or in the indenture with respect to the debt
securities;
●
any depositaries,
interest rate calculation agents, exchange rate calculation agents
or other agents with respect to the debt securities;
●
any other terms of
the debt securities, which may supplement, modify or delete any
provision of the indenture as it applies to that series, including
any terms that may be required under applicable law or regulations
or advisable in connection with the marketing of the securities;
and
●
whether any of our
direct or indirect subsidiaries will guarantee the debt securities
of that series, including the terms of subordination, if any, of
such guarantees.
We may
issue debt securities that provide for an amount less than their
stated principal amount to be due and payable upon declaration of
acceleration of their maturity pursuant to the terms of the
indenture. We will provide you with information on the federal
income tax considerations and other special considerations
applicable to any of these debt securities in the applicable
prospectus supplement.
If we
denominate the purchase price of any of the debt securities in a
foreign currency or currencies or a foreign currency unit or units,
or if the principal of and any premium and interest on any series
of debt securities is payable in a foreign currency or currencies
or a foreign currency unit or units, we will provide you with
information on the restrictions, elections, general tax
considerations, specific terms and other information with respect
to that issue of debt securities and such foreign currency or
currencies or foreign currency unit or units in the applicable
prospectus supplement.
Transfer and Exchange
Each
debt security will be represented by either one or more global
securities registered in the name of a clearing agency registered
under the Exchange Act, which we refer to as the depositary, or a
nominee of the depositary (we will refer to any debt security
represented by a global debt security as a “book-entry debt
security”), or a certificate issued in definitive registered
form (we will refer to any debt security represented by a
certificated security as a “certificated debt
security”) as set forth in the applicable prospectus
supplement. Except as set forth under the heading “Global
Debt Securities and Book-Entry System” below, book-entry debt
securities will not be issuable in certificated form.
Certificated Debt Securities
You may
transfer or exchange certificated debt securities at any office we
maintain for this purpose in accordance with the terms of the
indenture. No service charge will be made for any transfer or
exchange of certificated debt securities, but we may require
payment of a sum sufficient to cover any tax or other governmental
charge payable in connection with a transfer or
exchange.
You may
effect the transfer of certificated debt securities and the right
to receive the principal of, premium and interest on certificated
debt securities only by surrendering the certificate representing
those certificated debt securities and either reissuance by us or
the trustee of the certificate to the new holder or the issuance by
us or the trustee of a new certificate to the new
holder.
Global Debt Securities and Book-Entry System
Each
global debt security representing book-entry debt securities will
be deposited with, or on behalf of, the depositary, and registered
in the name of the depositary or a nominee of the
depositary.
Covenants
We will
set forth in the applicable prospectus supplement any restrictive
covenants applicable to any issue of debt securities.
No Protection in the Event of a Change of Control
Unless
we state otherwise in the applicable prospectus supplement, the
debt securities will not contain any provisions which may afford
holders of the debt securities protection in the event we have a
change in control or in the event of a highly leveraged transaction
(whether or not such transaction results in a change in control)
which could adversely affect holders of debt
securities.
Consolidation, Merger and Sale of Assets
We may
not consolidate with or merge with or into, or convey, transfer or
lease all or substantially all of our properties and assets to any
person, which we refer to as a successor person,
unless:
●
we are the
surviving corporation or the successor person (if other than us) is
a corporation organized and validly existing under the laws of any
U.S. domestic jurisdiction and expressly assumes our obligations on
the debt securities and under the indenture; and
●
immediately after
giving effect to the transaction, no Default or Event of Default,
shall have occurred and be continuing.
Notwithstanding the above, any of our subsidiaries
may consolidate with, merge into or transfer all or part of its
properties to us.
Events of Default
“Event of
Default” means with respect to any series of debt securities,
any of the following:
●
default in the
payment of any interest upon any debt security of that series when
it becomes due and payable, and continuance of such default for a
period of 30 days (unless the entire amount of the payment is
deposited by us with the trustee or with a paying agent prior to
the expiration of the 30-day period);
●
default in the
payment of principal of any security of that series at its
maturity;
●
default in the
performance or breach of any other covenant or warranty by us in
the indenture (other than a covenant or warranty that has been
included in the indenture solely for the benefit of a series of
debt securities other than that series), which default continues
uncured for a period of 60 days after we receive written notice
from the trustee, or we and the trustee receive written notice from
the holders of not less than 25% in principal amount of the
outstanding debt securities of that series as provided in the
indenture;
●
certain voluntary
or involuntary events of bankruptcy, insolvency or reorganization
of us; and
●
any other Event of
Default provided with respect to debt securities of that series
that is described in the applicable prospectus
supplement.
No
Event of Default with respect to a particular series of debt
securities (except as to certain events of bankruptcy, insolvency
or reorganization) necessarily constitutes an Event of Default with
respect to any other series of debt securities. The occurrence of
certain Events of Default or an acceleration under the indenture
may constitute an event of default under certain indebtedness of
ours or our subsidiaries outstanding from time to
time.
We will
provide the trustee written notice of any Default or Event of
Default within 30 days of becoming aware of the occurrence of such
Default or Event of Default, which notice will describe in
reasonable detail the status of such Default or Event of Default
and what action we are taking or propose to take in respect
thereof.
If an
Event of Default with respect to debt securities of any series at
the time outstanding occurs and is continuing, then the trustee or
the holders of not less than 25% in principal amount of the
outstanding debt securities of that series may, by a notice in
writing to us (and to the trustee if given by the holders), declare
to be due and payable immediately the principal of (or, if the debt
securities of that series are discount securities, that portion of
the principal amount as may be specified in the terms of that
series) and accrued and unpaid interest, if any, on all debt
securities of that series. In the case of an Event of Default
resulting from certain events of bankruptcy, insolvency or
reorganization, the principal (or such specified amount) of and
accrued and unpaid interest, if any, on all outstanding debt
securities will become and be immediately due and payable without
any declaration or other act on the part of the trustee or any
holder of outstanding debt securities. At any time after a
declaration of acceleration with respect to debt securities of any
series has been made, but before a judgment or decree for payment
of the money due has been obtained by the trustee, the holders of a
majority in principal amount of the outstanding debt securities of
that series may rescind and annul the acceleration if all Events of
Default, other than the non-payment of accelerated principal and
interest, if any, with respect to debt securities of that series,
have been cured or waived as provided in the indenture. We refer
you to the prospectus supplement relating to any series of debt
securities that are discount securities for the particular
provisions relating to acceleration of a portion of the principal
amount of such discount securities upon the occurrence of an Event
of Default.
The
indenture provides that the trustee may refuse to perform any duty
or exercise any of its rights or powers under the indenture unless
the trustee receives indemnity satisfactory to it against any cost,
liability or expense which might be incurred by it in performing
such duty or exercising such right or power. Subject to certain
rights of the trustee, the holders of a majority in principal
amount of the outstanding debt securities of any series will have
the right to direct the time, method and place of conducting any
proceeding for any remedy available to the trustee or exercising
any trust or power conferred on the trustee with respect to the
debt securities of that series.
No
holder of any debt security of any series will have any right to
institute any proceeding, judicial or otherwise, with respect to
the indenture or for the appointment of a receiver or trustee, or
for any remedy under the indenture, unless:
●
that holder has
previously given to the trustee written notice of a continuing
Event of Default with respect to debt securities of that series;
and
●
the holders of not
less than 25% in principal amount of the outstanding debt
securities of that series have made written request, and offered
indemnity or security satisfactory to the trustee, to the trustee
to institute the proceeding as trustee, and the trustee has not
received from the holders of not less than a majority in principal
amount of the outstanding debt securities of that series a
direction inconsistent with that request and has failed to
institute the proceeding within 60 days.
Notwithstanding any
other provision in the indenture, the holder of any debt security
will have an absolute and unconditional right to receive payment of
the principal of, premium and any interest on that debt security on
or after the due dates expressed in that debt security and to
institute suit for the enforcement of payment.
The
indenture requires us, within 120 days after the end of our fiscal
year, to furnish to the trustee a statement as to compliance with
the indenture. If a Default or Event of Default occurs and is
continuing with respect to the securities of any series and if it
is known to a responsible officer of the trustee, the trustee shall
send to each securityholder of the securities of that series notice
of a Default or Event of Default within 90 days after it occurs or,
if later, after a responsible officer of the trustee has knowledge
of such Default or Event of Default. The indenture provides that
the trustee may withhold notice to the holders of debt securities
of any series of any Default or Event of Default (except in payment
on any debt securities of that series) with respect to debt
securities of that series if the trustee determines in good faith
that withholding notice is in the interest of the holders of those
debt securities.
Modification and Waiver
We
and the trustee may modify, amend or supplement the indenture or
the debt securities of any series without the consent of any holder
of any debt security:
●
to cure any
ambiguity, defect or inconsistency;
●
to comply with
covenants in the indenture described above under the heading
“Consolidation, Merger and Sale of
Assets”;
●
to provide for
uncertificated securities in addition to or in place of
certificated securities;
●
to add guarantees
with respect to debt securities of any series or secure debt
securities of any series;
●
to surrender any of
our rights or powers under the indenture;
●
to add covenants or
events of default for the benefit of the holders of debt securities
of any series;
●
to comply with the
applicable procedures of the applicable depositary;
●
to make any change
that does not adversely affect the rights of any holder of debt
securities;
●
to provide for the
issuance of and establish the form and terms and conditions of debt
securities of any series as permitted by the
indenture;
●
to effect the
appointment of a successor trustee with respect to the debt
securities of any series and to add to or change any of the
provisions of the indenture to provide for or facilitate
administration by more than one trustee; or
●
to comply with
requirements of the SEC in order to effect or maintain the
qualification of the indenture under the Trust Indenture
Act.
We may
also modify and amend the indenture with the consent of the holders
of at least a majority in principal amount of the outstanding debt
securities of each series affected by the modifications or
amendments. We may not make any modification or amendment without
the consent of the holders of each affected debt security then
outstanding if that amendment will:
●
reduce the amount
of debt securities whose holders must consent to an amendment,
supplement or waiver;
●
reduce the rate of
or extend the time for payment of interest (including default
interest) on any debt security;
●
reduce the
principal of or premium on or change the fixed maturity of any debt
security or reduce the amount of, or postpone the date fixed for,
the payment of any sinking fund or analogous obligation with
respect to any series of debt securities;
●
reduce the
principal amount of discount securities payable upon acceleration
of maturity;
●
waive a default in
the payment of the principal of, premium or interest on any debt
security (except a rescission of acceleration of the debt
securities of any series by the holders of at least a majority in
aggregate principal amount of the then outstanding debt securities
of that series and a waiver of the payment default that resulted
from such acceleration);
●
make the principal
of or premium or interest on any debt security payable in currency
other than that stated in the debt security;
●
make any change to
certain provisions of the indenture relating to, among other
things, the right of holders of debt securities to receive payment
of the principal of, premium and interest on those debt securities
and to institute suit for the enforcement of any such payment and
to waivers or amendments; or
●
waive a redemption
payment with respect to any debt security.
Except
for certain specified provisions, the holders of at least a
majority in principal amount of the outstanding debt securities of
any series may on behalf of the holders of all debt securities of
that series waive our compliance with provisions of the indenture.
The holders of a majority in principal amount of the outstanding
debt securities of any series may on behalf of the holders of all
the debt securities of such series waive any past default under the
indenture with respect to that series and its consequences, except
a default in the payment of the principal of, premium or any
interest on any debt security of that series; provided, however,
that the holders of a majority in principal amount of the
outstanding debt securities of any series may rescind an
acceleration and its consequences, including any related payment
default that resulted from the acceleration.
Defeasance of Debt Securities and Certain Covenants in Certain
Circumstances
Legal Defeasance
The
indenture provides that, unless otherwise provided by the terms of
the applicable series of debt securities, we may be discharged from
any and all obligations in respect of the debt securities of any
series (subject to certain exceptions). We will be so discharged
upon the irrevocable deposit with the trustee, in trust, of money
and/or U.S. government obligations or, in the case of debt
securities denominated in a single currency other than U.S.
dollars, government obligations of the government that issued or
caused to be issued such currency, that, through the payment of
interest and principal in accordance with their terms, will provide
money or U.S. government obligations in an amount sufficient in the
opinion of a nationally recognized firm of independent public
accountants or investment bank to pay and discharge each
installment of principal, premium and interest on and any mandatory
sinking fund payments in respect of the debt securities of that
series on the stated maturity of those payments in accordance with
the terms of the indenture and those debt securities.
This
discharge may occur only if, among other things, we have delivered
to the trustee an opinion of counsel stating that we have received
from, or there has been published by, the United States Internal
Revenue Service a ruling or, since the date of execution of the
indenture, there has been a change in the applicable United States
federal income tax law, in either case to the effect that, and
based thereon such opinion shall confirm that, the holders of the
debt securities of that series will not recognize income, gain or
loss for United States federal income tax purposes as a result of
the deposit, defeasance and discharge and will be subject to United
States federal income tax on the same amounts and in the same
manner and at the same times as would have been the case if the
deposit, defeasance and discharge had not occurred.
Defeasance of Certain Covenants
The
indenture provides that, unless otherwise provided by the terms of
the applicable series of debt securities, upon compliance with
certain conditions:
●
we may omit to
comply with the covenant described under the heading
“Consolidation, Merger and Sale of Assets” and certain
other covenants set forth in the indenture, as well as any
additional covenants which may be set forth in the applicable
prospectus supplement; and
●
any omission to
comply with those covenants will not constitute a Default or an
Event of Default with respect to the debt securities of that
series.
We
refer to this as covenant defeasance. The conditions
include:
●
depositing with the
trustee money and/or U.S. government obligations or, in the case of
debt securities denominated in a single currency other than U.S.
dollars, government obligations of the government that issued or
caused to be issued such currency, that, through the payment of
interest and principal in accordance with their terms, will provide
money in an amount sufficient in the opinion of a nationally
recognized firm of independent public accountants or investment
bank to pay and discharge each installment of principal of, premium
and interest on and any mandatory sinking fund payments in respect
of the debt securities of that series on the stated maturity of
those payments in accordance with the terms of the indenture and
those debt securities;
●
such deposit will
not result in a breach or violation of, or constitute a default
under the indenture or any other agreement to which we are a
party;
●
no Default or Event
of Default with respect to the applicable series of debt securities
shall have occurred or is continuing on the date of such deposit;
and
●
delivering to the
trustee an opinion of counsel to the effect that we have received
from, or there has been published by, the United States Internal
Revenue Service a ruling or, since the date of execution of the
indenture, there has been a change in the applicable United States
federal income tax law, in either case to the effect that, and
based thereon such opinion shall confirm that, the holders of the
debt securities of that series will not recognize income, gain or
loss for United States federal income tax purposes as a result of
the deposit and related covenant defeasance and will be subject to
United States federal income tax on the same amounts and in the
same manner and at the same times as would have been the case if
the deposit and related covenant defeasance had not
occurred.
No Personal Liability of Directors, Officers, Employees or
Shareholders
None of
our past, present or future directors, officers, employees or
stockholders, as such, will have any liability for any of our
obligations under the debt securities or the indenture or for any
claim based on, or in respect or by reason of, such obligations or
their creation. By accepting a debt security, each holder waives
and releases all such liability. This waiver and release is part of
the consideration for the issue of the debt securities. However,
this waiver and release may not be effective to waive liabilities
under U.S. federal securities laws, and it is the view of the SEC
that such a waiver is against public policy.
Governing Law
The
indenture and the debt securities, including any claim or
controversy arising out of or relating to the indenture or the
securities, will be governed by the laws of the State of New
York.
The
indenture will provide that we, the trustee and the holders of the
debt securities (by their acceptance of the debt securities)
irrevocably waive, to the fullest extent permitted by applicable
law, any and all right to trial by jury in any legal proceeding
arising out of or relating to the indenture, the debt securities or
the transactions contemplated thereby.
The
indenture will provide that any legal suit, action or proceeding
arising out of or based upon the indenture or the transactions
contemplated thereby may be instituted in the federal courts of the
United States of America located in the City of New York or the
courts of the State of New York in each case located in the City of
New York, and we, the trustee and the holder of the debt securities
(by their acceptance of the debt securities) irrevocably submit to
the non-exclusive jurisdiction of such courts in any such suit,
action or proceeding. The indenture will further provide that
service of any process, summons, notice or document by mail (to the
extent allowed under any applicable statute or rule of court) to
such party’s address set forth in the indenture will be
effective service of process for any suit, action or other
proceeding brought in any such court. The indenture will further
provide that we, the trustee and the holders of the debt securities
(by their acceptance of the debt securities) irrevocably and
unconditionally waive any objection to the laying of venue of any
suit, action or other proceeding in the courts specified above and
irrevocably and unconditionally waive and agree not to plead or
claim any such suit, action or other proceeding has been brought in
an inconvenient forum.
PLAN OF DISTRIBUTION
We may
sell securities:
●
directly to
purchasers, including our affiliates; or
●
through a
combination of any of these methods of sale.
In
addition, we may issue the securities as a dividend or distribution
or in a subscription rights offering to our existing
securityholders.
We may
directly solicit offers to purchase securities or agents may be
designated to solicit such offers. We will, in the prospectus
supplement relating to such offering, name any agent that could be
viewed as an underwriter under the Securities Act and describe any
commissions that we must pay. Any such agent will be acting on a
best efforts basis for the period of its appointment or, if
indicated in the applicable prospectus supplement, on a firm
commitment basis. This prospectus may be used in connection with
any offering of our securities through any of these methods or
other methods described in the applicable prospectus
supplement.
The
distribution of the securities may be effected from time to time in
one or more transactions:
●
at a fixed price or
prices that may be changed from time to time;
●
at market prices
prevailing at the time of sale;
●
at prices related
to such prevailing market prices; or
Each
prospectus supplement will describe the method of distribution of
the securities and any applicable restrictions.
We may
use any one or more of the following methods when selling
securities:
●
underwritten
transactions;
●
privately
negotiated transactions;
●
sales through the
Nasdaq Global Market or on any national securities exchange or
quotation service on which the shares of common stock may be listed
or quoted at the time of sale;
●
sales
in the over-the-counter market;
●
ordinary brokerage
transactions and transactions in which the broker solicits
purchasers;
●
broker-dealers may
agree with the selling stockholders to sell a specified number of
such securities at a stipulated price per share;
●
a block trade
(which may involve crosses) in which the broker-dealer so engaged
will attempt to sell the securities as agent but may position and
resell a portion of the block as principal to facilitate the
transaction;
●
purchases by a
broker-dealer as principal and resale by such broker-dealer for its
own account pursuant to this prospectus;
●
“at the
market” offerings to or through a market maker or into an
existing trading market, on an exchange or otherwise;
●
exchange
distributions and/or secondary distributions;
●
short sales and
delivery of shares of common stock to close out short
positions;
●
sales by
broker-dealers of shares of common stock that are loaned or pledged
to such broker-dealers;
●
a combination of
any such methods of sale; and
●
any
other method permitted pursuant to applicable law.
The
prospectus supplement with respect to the securities of a
particular series will describe the terms of the offering of the
securities, including the following:
●
the terms of the
offering;
●
the name of the
agent or any underwriters;
●
the
name or names of any managing underwriter or
underwriters;
●
the public offering
or purchase price;
●
the net proceeds
from the sale of the securities;
●
any delayed
delivery arrangements;
●
any discounts and
commissions to be allowed or paid to the agent or
underwriters;
●
any initial price
to the public;
●
all other items
constituting underwriting compensation;
●
any discounts and
commissions to be allowed or paid to dealers;
●
any commissions
paid to agents and
●
any exchanges on
which the securities will be listed.
Sale through Underwriters or Dealers
If any
underwriters or agents are utilized in the sale of the securities
in respect of which this prospectus is delivered, we will enter into an underwriting
agreement or other agreement with them at the time of sale to them,
and we will set forth in the prospectus supplement relating to such
offering the names of the underwriters or agents and the terms of
the related agreement with them.
If a
dealer is utilized in the sale of the securities in respect of
which the prospectus is delivered, we will sell such securities to
the dealer, as principal. The dealer may then resell such
securities to the public at varying prices to be determined by such
dealer at the time of resale.
Agents,
underwriters, dealers and other persons may be entitled under
agreements that they may enter into with us to indemnification by us against
certain civil liabilities, including liabilities under the
Securities Act.
If so
indicated in the applicable prospectus supplement, we will
authorize underwriters or other persons acting as our agents to
solicit offers by certain institutions to purchase securities from
us pursuant to delayed delivery contracts providing for payment and
delivery on the date stated in the prospectus supplement. Each
contract will be for an amount not less than, and the aggregate
amount of securities sold pursuant to such contracts shall not be
less nor more than, the respective amounts stated in the prospectus
supplement. Institutions with whom the contracts, when authorized,
may be made include commercial and savings banks, insurance
companies, pension funds, investment companies, educational and
charitable institutions and other institutions, but shall in all
cases be subject to our approval. Delayed delivery contracts will
not be subject to any conditions except that:
●
the purchase by an
institution of the securities covered under that contract shall not
at the time of delivery be prohibited under the laws of the
jurisdiction to which that institution is subject; and
●
if the securities
are also being sold to underwriters acting as principals for their
own account, the underwriters shall have purchased such securities
not sold for delayed delivery.
The
underwriters and other persons acting as agents will not have any
responsibility in respect of the validity or performance of delayed
delivery contracts.
Certain
agents, underwriters and dealers, and their associates and
affiliates may be customers of, have borrowing relationships with,
engage in other transactions with, and/or perform services,
including investment banking services, for us or one or more of our
respective affiliates in the ordinary course of
business.
In
order to facilitate the offering of the securities, any
underwriters may engage in transactions that stabilize, maintain or
otherwise affect the price of the securities or any other
securities the prices of which may be used to determine payments on
such securities. Specifically, any underwriters may over-allot in
connection with the offering, creating a short position for their
own accounts. In addition, to cover over-allotments or to stabilize
the price of the securities or of any such other securities, the
underwriters may bid for, and purchase, the securities or any such
other securities in the open market. Finally, in any offering of
the securities through a syndicate of underwriters, the
underwriting syndicate may reclaim selling concessions allowed to
an underwriter or a dealer for distributing the securities in the
offering if the syndicate repurchases previously distributed
securities in transactions to cover syndicate short positions, in
stabilization transactions or otherwise. Any of these activities
may stabilize or maintain the market price of the securities above
independent market levels. Any such underwriters are not required
to engage in these activities and may end any of these activities
at any time.
Under
Rule 15c6-1 of the Exchange Act, trades in the secondary
market generally are required to settle in two business days,
unless the parties to any such trade expressly agree otherwise. The
applicable prospectus supplement may provide that the original
issue date for your securities may be more than two scheduled
business days after the trade date for your securities.
Accordingly, in such a case, if you wish to trade securities on any
date prior to the third business day before the original issue date
for your securities, you will be required, by virtue of the fact
that your securities initially are expected to settle in more than
three scheduled business days after the trade date for your
securities, to make alternative settlement arrangements to prevent
a failed settlement.
The
securities may be new issues of securities and may have no
established trading market. The securities may or may not be listed
on a national securities exchange. We can make no assurance as to
the liquidity of or the existence of trading markets for any of the
securities.
Direct Sales and Sales through Agents
We may
sell the securities offered through this prospectus directly. In
this case, no underwriters or agents would be involved. Such
securities may also be sold through agents designated from time to
time. Any required prospectus supplement will name any agent
involved in the offer or sale of the offered securities and will
describe any commissions payable to the agent by us. Unless
otherwise indicated in the prospectus supplement, any agent will
agree to use its reasonable best efforts to solicit purchases for
the period of its appointment.
We may
sell the securities directly to institutional investors or others
who may be deemed to be underwriters within the meaning of the
Securities Act with respect to any sale of those
securities.
Delayed Delivery Contracts
If the
prospectus supplement indicates, we may authorize agents,
underwriters or dealers to solicit offers from certain types of
institutions to purchase securities at the public offering price
under delayed delivery contracts. These contracts would provide for
payment and delivery on a specified date in the future. The
contracts would be subject only to those conditions described in
the prospectus supplement. The applicable prospectus supplement
will describe the commission payable for solicitation of those
contracts.
At-the-Market Offerings
We may
engage in at-the-market offerings into an existing trading market
in accordance with Rule 415(a)(4). To the extent that we make
sales through one or more underwriters or agents in at-the-market
offerings, we will do so pursuant to the terms of a sales agency
financing agreement or other at-the-market offering arrangement
between us, on one hand, and the underwriters or agents, on the
other. If we engage in at-the-market sales pursuant to any such
agreement, we will sell our securities through one or more
underwriters or agents, which may act on an agency basis or a
principal basis. During the term of any such agreement, we may sell
securities on a daily basis in exchange transactions or otherwise
as we agree with the underwriters or agents. Any such agreement
will provide that any securities sold will be sold at prices
related to the then prevailing market prices for our securities.
Therefore, exact figures regarding proceeds that will be raised or
commissions to be paid cannot be determined as of the date of this
prospectus. Pursuant to the terms of the agreement, we may agree to
sell, and the relevant underwriters or agents may agree to solicit
offers to purchase, blocks of our common stock or other securities.
The terms of any such agreement will be set forth in more detail in
the applicable prospectus or prospectus supplement.
Market Making, Stabilization and Other Transactions
Unless
the applicable prospectus supplement states otherwise, each series
of offered securities by us will be a new issue and will have no
established trading market. We may elect to list any series of
offered securities on an exchange. Any underwriters that we use in
the sale of offered securities may make a market in such
securities, but may discontinue such market making at any time
without notice. Accordingly, we cannot assure you that the
securities will have a liquid trading market.
Any
underwriter may also over-allot or engage in stabilizing
transactions, syndicate covering transactions and penalty bids in
accordance with Rule 104 under the Exchange Act.
Over-allotment or short sales involve sales by persons
participating in the offering of more securities than were sold to
them. In these circumstances, these persons would cover such
over-allotments or short positions by making purchases in the open
market or by exercising their over-allotment option, if any.
Stabilizing transactions involve bids to purchase the underlying
security in the open market for the purpose of pegging, fixing or
maintaining the price of the securities. Syndicate covering
transactions involve purchases of the securities in the open market
after the distribution has been completed in order to cover
syndicate short positions.
Penalty
bids permit the underwriters to reclaim a selling concession from a
syndicate member when the securities originally sold by the
syndicate member are purchased in a syndicate covering transaction
to cover syndicate short positions. Stabilizing transactions,
syndicate covering transactions and penalty bids may cause the
price of the securities to be higher than it would be in the
absence of the transactions. The underwriters may, if they commence
these transactions, discontinue them at any time.
Derivative Transactions and Hedging
We, the
underwriters or other agents may engage in derivative transactions
involving the securities. These derivatives may consist of short
sale transactions and other hedging activities. The underwriters or
agents may acquire a long or short position in the securities, hold
or resell securities acquired and purchase options or futures on
the securities and other derivative instruments with returns linked
to or related to changes in the price of the securities. In order
to facilitate these derivative transactions, we may enter into
security lending or repurchase agreements with the underwriters or
agents. The underwriters or agents may effect the derivative
transactions through sales of the securities to the public,
including short sales, or by lending the securities in order to
facilitate short sale transactions by others. The underwriters or
agents may also use the securities purchased or borrowed from us or
others (or, in the case of derivatives, securities received from us
in settlement of those derivatives) to directly or indirectly
settle sales of the securities or close out any related open
borrowings of the securities.
Electronic Auctions
We may
also make sales through the Internet or through other electronic
means. Since we may from time to time elect to offer securities
directly to the public, with or without the involvement of agents,
underwriters or dealers, utilizing the Internet or other forms of
electronic bidding or ordering systems for the pricing and
allocation of such securities, you should pay particular attention
to the description of that system we will provide in a prospectus
supplement.
Such
electronic system may allow bidders to directly participate,
through electronic access to an auction site, by submitting
conditional offers to buy that are subject to acceptance by us, and
which may directly affect the price or other terms and conditions
at which such securities are sold. These bidding or ordering
systems may present to each bidder, on a so-called
“real-time” basis, relevant information to assist in
making a bid, such as the clearing spread at which the offering
would be sold, based on the bids submitted, and whether a
bidder’s individual bids would be accepted, prorated or
rejected. For example, in the case of a debt security, the clearing
spread could be indicated as a number of “basis points”
above an index treasury note. Of course, many pricing methods can
and may also be used.
Upon
completion of such an electronic auction process, securities will
be allocated based on prices bid, terms of bid or other factors.
The final offering price at which securities would be sold and the
allocation of securities among bidders would be based in whole or
in part on the results of the Internet or other electronic bidding
process or auction.
General Information
Agents,
underwriters and dealers may be entitled, under agreements entered
into with us, to indemnification by us against certain liabilities,
including liabilities under the Securities Act. Agents,
underwriters and dealers, or their affiliates, may engage in
transactions with or perform services for us in the ordinary course
of their businesses.
Any
agents, underwriters or dealers that are involved in selling shares
of our common stock may be deemed to be “underwriters”
within the meaning of the Securities Act in connection with such
sales. In such event, any commissions received by such agents,
underwriters or dealers and any profit on the resale of shares of
our common stock purchased by them may be deemed to be underwriting
commissions or discounts under the Securities Act.
LEGAL MATTERS
The
validity of the securities offered hereby will be passed upon for
us by Ballard Spahr LLP, Las Vegas, Nevada. Additional legal
matters may be passed on for us, or any underwriters, dealers or
agents by counsel we will name in the applicable prospectus
supplement.
EXPERTS
The
consolidated financial statements incorporated in this Prospectus by reference to
the Annual Report on Form 10-K for the year ended February 28,
2021 have been so incorporated in reliance on the report of
PricewaterhouseCoopers LLP, an
independent registered public accounting firm, given on the
authority of said firm as experts in auditing and
accounting.
WHERE YOU CAN FIND MORE INFORMATION
We file
annual, quarterly and current reports, proxy statements and other
information with the SEC. Our SEC filings are available to the
public over the Internet at the SEC’s website at www.sec.gov. Copies of certain
information filed by us with the SEC are also available on our
website at www.loopindustries.com. Information
accessible on or through our website is not a part of this
prospectus.
This
prospectus and any prospectus supplement is part of a registration
statement that we filed with the SEC and do not contain all of the
information in the registration statement. You should review the
information and exhibits in the registration statement for further
information on us and our consolidated subsidiaries and the
securities that we are offering. Forms of any indenture or other
documents establishing the terms of the offered securities are
filed as exhibits to the registration statement of which this
prospectus forms a part or under cover of a Current Report on Form
8-K and incorporated in this prospectus by reference. Statements in
this prospectus or any prospectus supplement about these documents
are summaries and each statement is qualified in all respects by
reference to the document to which it refers. You should read the
actual documents for a more complete description of the relevant
matters.
INCORPORATION BY REFERENCE
The SEC
allows us to incorporate by reference much of the information that
we file with the SEC, which means that we can disclose important
information to you by referring you to those publicly available
documents. The information that we incorporate by reference in this
prospectus is considered to be part of this prospectus. Because we
are incorporating by reference future filings with the SEC, this
prospectus is continually updated and those future filings may
modify or supersede some of the information included or
incorporated by reference in this prospectus. This means that you
must look at all of the SEC filings that we incorporate by
reference to determine if any of the statements in this prospectus
or in any document previously incorporated by reference have been
modified or superseded. This prospectus incorporates by reference
the documents listed below and any future filings we make with the
SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange
Act (in each case, other than those documents or the portions of
those documents furnished pursuant to Items 2.02 or 7.01 of any
Current Report on Form 8-K and, except as may be noted in any
such Form 8-K, exhibits filed on such form that are related to
such information), until the offering of the securities under the
registration statement of which this prospectus forms a part is
terminated or completed:
●
our Annual Report
on Form 10-K for the year ended February 28, 2021, filed with the
SEC on June 1, 2021;
●
our Quarterly
Report on Form 10-Q for the quarter ended May 31, 2021, filed with
the SEC on July 15, 2021;
●
the portions of our
Definitive Proxy Statement on Schedule 14A (other than
information furnished rather than filed) that are incorporated by
reference into our Annual Report on Form 10-K, filed with the
SEC on June 1, 2021;
●
our Current Reports
on Form 8-K filed on June 23, 2021 (other than information
furnished rather than filed) and June 30, 2021; and
●
The description of
our common stock contained in
the Registration Statement on Form 8-A relating thereto (Commission
File No. 001-38301), filed on November 17, 2017, including any
amendment or report filed for the purpose of updating such
description.
Notwithstanding the
statements in the preceding paragraphs, no document, report or
exhibit (or portion of any of the foregoing) or any other
information that we have “furnished” or may in the
future “furnish” to the SEC pursuant to the Exchange
Act shall be incorporated by reference into this
prospectus.
You may
request a copy of these filings, at no cost, by writing or
telephoning us at the following address:
Loop
Industries, Inc.
480
Fernand-Poitras Terrebonne
Québec,
Canada J6Y 1Y4
Attn:
Investor Relations
(450)
951-8555
$175,000,000
Common Stock
Preferred Stock
Debt Securities
PROSPECTUS